These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Prophylaxis of cytomegalovirus disease with intravenous ganciclovir in renal transplantation. Sancho A; Górriz JL; Crespo JF; Avila A; Alcaraz MJ; García Ramos JL; Pallardó LM Transplant Proc; 1999 Sep; 31(6):2337-8. PubMed ID: 10500606 [No Abstract] [Full Text] [Related]
13. Cost-effectiveness model of cytomegalovirus management strategies in renal transplantation. Comparing valaciclovir prophylaxis with current practice. Mauskopf JA; Richter A; Annemans L; Maclaine G Pharmacoeconomics; 2000 Sep; 18(3):239-51. PubMed ID: 11147391 [TBL] [Abstract][Full Text] [Related]
14. Prophylaxis of cytomegalovirus infection in renal transplantation: new data for an old problem. Kuypers DR; Vanrenterghem YF Nephrol Dial Transplant; 1999 Oct; 14(10):2304-8. PubMed ID: 10528649 [No Abstract] [Full Text] [Related]
15. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease]. Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888 [TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus infection after liver transplantation using different prophylaxes. Kornberg A; Grube T; Hommann M; Schotte U; Scheele J Transplant Proc; 2001; 33(7-8):3624-5. PubMed ID: 11750539 [No Abstract] [Full Text] [Related]